Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...

Health-care companies fell as traders weighed risks in a wave of deal activity. Pfizer joined Big Pharma rivals hunting for novel weight loss drugs in the Chinese biotech sector.

Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply ...

Jeff Williams, a former Apple executive, will stand for election as a new independent director of Disney at the 2026 annual ...

The executive, who would expand the size of the board to a total of 11 members, will stand election at the media giant's 2026 annual meeting of shareholders ...

Dow Jones Top Company Headlines at 5 PM ET: JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks May Have to Keep Up. | Nvidia ... JPMorgan Stock Sinks on Higher Expense Outlook. Other Banks ...

As Adam Fein of Drug Channels Institute puts it, these forces are finally puncturing the “ gross-to-net bubble ”—the vast gap ...

The Florida Gators have a new football coach but that coach, Jon Sumrall, is still coaching Tulane, which plays North Texas Friday night.

The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...

Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create ...